한글목차

세계 부신피질 호르몬 API 시장의 미래는 주사제, 경구제, 외용제, 흡입제 시장에 기회가 있을 것으로 보입니다. 세계 부신피질 호르몬 API 시장은 2025-2031년 연평균 복합 성장률(CAGR) 5.9%를 보일 것으로 예측됩니다. 이 시장의 주요 촉진요인은 호르몬 대체요법에 대한 수요 증가와 부신기능부전 질환의 유병률 증가입니다.

• Lucintel의 예측에 따르면 유형별로는 프레드니손 계열이 예측 기간 중 가장 높은 성장세를 보일 것으로 예측됩니다.
• 용도별로는 주사제가 가장 높은 성장이 예상됩니다.
• 지역별로는 북미가 예측 기간 중 가장 높은 성장세를 보일 것으로 예측됩니다.

부신피질 호르몬 API 시장의 전략적 성장 기회

부신피질 호르몬 API 시장은 주요 용도와 관련된 몇 가지 전략적 성장 기회가 존재합니다. 이는 급속한 기술 혁신, 표적 치료에 대한 새로운 수요, 시장에서의 니즈 확대에 기인합니다.

• 만성 부신 기능 부전 치료에 대한 적용: 만성 부신 기능 부전의 전반적인 유병률은 부신피질 호르몬 API에 큰 기회를 제공합니다. 환자들의 요구를 충족시키고 이 질환에 대한 치료 성적을 향상시킬 수 있는 고급 치료법 및 개량형 제제의 개발이 필요합니다.
• 종양학에서의 활용: 부신피질 호르몬은 암 치료 중에서도 암의 증상 관리를 위한 치료에 적용되고 있습니다. 이러한 용도 및 표적치료에 대한 연구의 진전은 종양학 시장에 새로운 기회를 가져올 것입니다.
• 자가면역질환 관리: 애디슨병, 류마티스 관절염과 같은 자가면역질환 관리에서 호르몬 치료의 필요성이 증가함에 따라 이 치료 분야에서 특수 부신피질호르몬 API 개발의 기회가 창출되고 있습니다.
• 개인화된 부신피질 호르몬 치료: 개인화된 의료는 맞춤형 부신피질 호르몬 치료를 제공할 수 있는 독특한 기회를 제공합니다. 이러한 치료법은 환자 프로파일에 따라 처방되어 더 나은 효과와 적은 부작용을 제공하므로 개인화된 의료 솔루션에 대한 수요를 충족시킬 수 있습니다.
• 신흥 시장 확대: 신흥 시장은 부신피질 호르몬 API에 유망한 개발 기회를 제공합니다. 이들 지역으로의 진출은 새로운 고객을 확보하고, 의료 인프라를 강화하며, 호르몬을 포함한 효과적인 치료제에 대한 수요 증가에 대응할 수 있습니다.

부신피질 호르몬 API 시장에서는 만성 부신 기능 부전 치료, 종양학 응용, 자가면역질환 관리, 개인 맞춤형 호르몬 요법, 신흥 시장 등이 전략적 성장 기회로 작용할 수 있습니다. 이러한 기회는 사업 확장, 기술 혁신, 의료 수요와 동향에 더 잘 부합할 수 있는 길을 열어줄 것으로 보입니다.

부신피질호르몬 API 시장 성장 촉진요인 및 과제

부신피질 호르몬 API 시장에서는 다양한 요인이 시장 성장 촉진요인으로 작용하는 반면, 기술적 요인, 경제적 요인, 규제적 고려사항과 같은 과제가 이러한 요인의 균형을 맞추고 있습니다. 명확한 이해는 시장을 효과적으로 탐색하는 데 도움이 됩니다.

부신피질 호르몬 API 시장 성장 촉진요인은 다음과 같습니다.

• 기술 발전: 합성법 및 제제 기술 발전 등 호르몬 원료의약품 생산과 관련된 기술의 혁신적 개발은 제품의 품질과 효능을 향상시키고 시장 성장을 가속합니다. 이러한 개발은 부신피질 호르몬과 관련된 새로운 치료법 및 개선된 치료법의 개발을 지원합니다.
• 표적치료에 대한 수요 증가: 표적치료 및 맞춤치료에 대한 수요 증가는 표적 부신피질 호르몬 API에 대한 수요 증가의 근거가 됩니다. 이러한 수요는 다양한 인구 집단과 질환을 대상으로 한 기술 혁신을 촉진하고 시장 성장을 가속화할 것입니다.
• 호르몬 질환의 유병률 증가: 부신기능부전 및 자가면역질환과 같은 호르몬 질환의 유병률 증가는 부신피질 호르몬 API에 대한 수요를 촉진하고 있습니다. 이러한 질환을 효과적인 제제로 치료하는 것은 시장 성장에 크게 기여할 것입니다.
• R&D 투자: R&D 투자 증가는 부신피질 호르몬 API의 발전을 지원하고 있습니다. R&D는 새로운 제형 개발, 기존 치료법의 강화, 다른 적응증 발굴에 중점을 두고 있습니다.
• 혁신을 지원하는 규제 프레임워크: 새로운 부신피질 호르몬 API를 승인하기 위한 지원적인 규제 환경과 간소화된 절차는 시장 진입을 촉진합니다. 제품의 안전성을 보장하면서 승인을 신속히 처리하기 위한 규제기관 관련 활동은 시장 성장에 기여하고 있습니다.

부신피질 호르몬 API 시장이 해결해야 할 과제는 다음과 같습니다.

• 규제 복잡성: 복잡한 규제 요건과 끊임없이 변화하는 컴플라이언스 기준은 큰 도전이 되고 있습니다. 안전성과 유효성 기준을 충족하는 데 필요한 규제 관련 지식과 프로세스는 비용과 시간이 많이 들지만, 시장 승인에 필수적인 투자입니다.
• 높은 제조비용: 고가의 부신피질 호르몬 API를 제조하기 위해서는 고가의 원료와 첨단 기술이 필요한 경우가 많습니다. 제품의 품질을 보장하면서 제조 비용을 통제하는 것은 매우 중요합니다.
• 공급망 혼란: 공급망 혼란은 호르몬 원료의약품의 가용성과 가격에 영향을 미치는 원자재 부족 및 물류 문제를 야기할 수 있습니다. 따라서 탄력성을 확보하고 이러한 문제를 완화할 수 있는 공급망 전략 수립이 필수적입니다.

부신피질 호르몬 API 시장의 주요 촉진요인으로는 기술 발전, 표적 치료에 대한 수요 증가, 호르몬 질환의 유병률 증가, R&D 투자, 규제 당국의 지원 등을 들 수 있습니다. 또한 성공하기 위해서는 규제 장벽을 극복하고, 높은 생산 비용을 관리하고, 공급망 혼란을 해결하는 것이 중요한 과제입니다.

목차

제1장 개요

제2장 세계의 부신피질 호르몬 API 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 부신피질 호르몬 API 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 부신피질 호르몬 API 시장 : 유형별
  • Prednisone Series
  • Dexamethasone Series
  • Betamethasone Series
  • Hydrocortisone Series
  • 기타
• 세계의 부신피질 호르몬 API 시장 : 용도별
  • 주사제
  • 경구약
  • 외용약
  • 흡입약

제4장 지역별 시장 동향과 예측 분석(2019-2031년)

• 세계의 부신피질 호르몬 API 시장 : 지역별
• 북미의 부신피질 호르몬 API 시장
• 유럽의 부신피질 호르몬 API 시장
• 아시아태평양의 부신피질 호르몬 API 시장
• 기타 지역의 부신피질 호르몬 API 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 부신피질 호르몬 API 시장의 성장 기회 : 유형별
  • 세계의 부신피질 호르몬 API 시장의 성장 기회 : 용도별
  • 세계의 부신피질 호르몬 API 시장의 성장 기회 : 지역별
• 세계의 부신피질 호르몬 API 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 부신피질 호르몬 API 시장의 생산능력 확대
  • 세계의 부신피질 호르몬 API 시장에서의 기업인수합병(M&A), 합병사업
  • 인증과 라이선싱

제7장 주요 기업의 개요

• Pfizer CentreOne
• EuroAPI
• GlaxoSmithKline
• Teva Pharmaceutical Industries
• Hovione
• Axplora
• Steroid Spa
• Avik Pharmaceutical
• Anuh Pharma
• Symbiotec Pharmalab

영문목차

The future of the global adrenocortical hormone API market looks promising with opportunities in the injectable drug, oral drug, for external use drug, and inhalation drug markets. The global adrenocortical hormone API market is expected to grow with a CAGR of 5.9% from 2025 to 2031. The major drivers for this market are the growing demand for hormonal replacement therapies and rising prevalence of adrenal insufficiency disorders.

• Lucintel forecasts that, within the type category, the prednisone series is expected to witness the highest growth over the forecast period.
• Within the application category, the injectable drug is expected to witness the highest growth.
• In terms of regions, North America is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Adrenocortical Hormone API Market

Indeed, several emerging trends have pushed the growth of the adrenocortical hormone API market due to technological advancement, changes in regulation, and a shift in demand within the market. These current trends affect the development, production, and distribution of adrenocortical hormone APIs.

• Advancement in Drug Delivery Systems: New delivery systems for drugs, including extended-release and targeted methods of delivery, are part of the developments that make adrenocortical hormones more effective. This provides better patient compliance because these hormones can now be released in a better-controlled and more sustained way, improving therapeutic results.
• Personalized Medicine: Personalized medicine is generating growing interest in the adrenocortical hormone market. Such therapies, tailored to individual genetic profiles and specific disease conditions, will be more efficient and focused, thus promising better results for patients with fewer side effects.
• Production Capacity Expansion: Pharmaceutical firms are investing in the expansion of their manufacturing capacities to meet growing global demand. Upgrading facilities and adopting advanced technology at the manufacturing site assists companies in maintaining product quality and availability in the market.
• Regulatory Enhancements and Compliance: Regulatory bodies are implementing stricter guidelines and standards for the manufacture of hormone APIs. Companies are focusing on achieving compliance with enhanced regulations to ensure customer safety and market approval in various regions.
• Growing Research and Development Efforts: Increased R&D efforts are among the leading factors ensuring innovation in adrenocortical hormone APIs. Research focuses on new formulations, improvements of existing therapies, and finding novel applications of hormone APIs across different therapeutic fields.

Trends such as the development of drug delivery systems, personalized medicine, increased production capacity, regulatory improvements, and extensive R&D are transforming the adrenocortical hormone API market. Thus, these trends are driving innovation, optimizing product offerings by responding to new market needs and adapting to changing regulatory requirements.

Recent Developments in the Adrenocortical Hormone API Market

The developing pattern in the adrenocortical hormone API market is influenced by changing technological scales, regulatory frameworks, and market demands. The future and growth of the market are marked by new developments.

• Innovation in Formulation Technologies: Advances in formulation technologies are resulting in increased potency and stability of adrenocortical hormone APIs. Some of the new formulations include nanoparticle-based delivery systems that improve the bioavailability of hormones and their therapeutic use.
• Regulatory Approvals for New Products: The number of regulatory approvals now allows a wider range of therapeutic options for several new adrenocortical hormone APIs. These approvals enable companies to introduce innovative products to address unmet medical needs in hormone therapy.
• Increased Investment in Biotech Startups: Investments in biotech startups specializing in the production of adrenocortical hormones are growing. The development of new hormone active pharmaceutical ingredients and innovative delivery methods improves market growth prospects and competitiveness.
• Technological Upgrades in Manufacturing: One of the most important areas of visible technological advancement is in manufacturing technologies. Companies are investing more in automation, real-time monitoring, and quality control to establish consistency and reliability in production processes.
• Emerging Market Expansion: The API market for adrenocortical hormone development is expanding in emerging markets due to high demand and better healthcare infrastructure. Companies are establishing their presence in these regions to capitalize on growth opportunities and meet local market demands.

In general, key developments in innovation in formulation technologies, regulatory approvals, increased investment in biotech startups, technological upgrades in manufacturing, and penetration into emerging markets act as growth drivers in the adrenocortical hormone API market. These developments offer opportunities for value addition to product offerings and streamlining of the manufacturing process while presenting new markets.

Strategic Growth Opportunities for the Adrenocortical Hormone API Market

There are several strategic growth opportunities related to key applications in the adrenocortical hormone API market. This is attributed to rapid technological changes, emerging demand for targeted therapies, and expanding needs in the marketplace.

• Application in Chronic Adrenal Insufficiency Treatments: The overall prevalence of chronic adrenal insufficiency presents a significant opportunity for adrenocortical hormone APIs. There is a need for developing advanced treatments and improved formulations that can meet patient needs and improve therapeutic outcomes related to the condition.
• Applications in Oncology: Adrenocortical hormones are applied in treatments for symptom management of cancers, among other oncology treatments. Growing research on these applications and targeted therapies will open up new opportunities in the oncology market.
• Managing Autoimmune Diseases: The growing need for hormone therapies in managing autoimmune diseases such as Addison's disease and rheumatoid arthritis creates opportunities for developing specialized adrenocortical hormone APIs in this therapeutic segment.
• Personalized Adrenocortical Hormone Therapies: Personalized medicine offers a unique opportunity to provide customized adrenocortical hormone therapies. These therapies would be prescribed according to a patient profile, offering better efficacy and fewer side effects, thus responding to a demand for personalized healthcare solutions.
• Emerging Market Expansion: Emerging markets provide promising development opportunities for adrenocortical hormone APIs. Expanding into these regions will attract new customers, increase healthcare infrastructure, and meet the growing demand for effective treatments that include hormones.

In the adrenocortical hormone API market, strategic growth opportunities will encompass treatments for chronic adrenal insufficiency, applications in oncology, management of autoimmune diseases, personalized hormone therapies, and emerging markets. Such opportunities will pave the way for business expansion, innovation, and better alignment with healthcare needs and trends.

Adrenocortical Hormone API Market Driver and Challenges

Various factors act as drivers in the adrenocortical hormone API market, while challenges such as technological, economic factors, and regulatory considerations will balance these. A clear understanding will assist in navigating the market effectively.

The factors responsible for driving the adrenocortical hormone API market include:

• Technological Advancement: Innovative developments in technologies related to the production of hormone APIs, including advancements in synthesis methods and formulation technologies, enhance product quality and effectiveness, thus driving market growth. These advancements support the development of new and improved therapies related to adrenocortical hormones.
• Increasing Demand for Targeted Therapies: Growth in demand for targeted and personalized therapies creates a rationale for increased demand for targeted adrenocortical hormone APIs. This demand drives innovation aimed at different populations and disease states, accelerating market growth.
• Growing Prevalence of Hormonal Disorders: The growing prevalence of hormonal disorders, including adrenal insufficiency and autoimmune diseases, fuels demand for adrenocortical hormone APIs. Treating these conditions with effective formulations contributes significantly to market growth.
• Investment in R&D: Increasing research and development investments support the advancement of adrenocortical hormone APIs. R&D focuses on developing new formulations, enhancing existing therapies, and identifying other indications.
• Supportive Regulatory Framework for Innovation: Supportive regulatory environments and streamlined procedures for approving new adrenocortical hormone APIs facilitate market access. Activities related to regulatory bodies to expedite approvals while ensuring product safety contribute to market growth.

Challenges in the adrenocortical hormone API market include:

• Regulatory Complexity: Complex regulatory requirements and ever-changing compliance standards pose significant challenges. The regulatory knowledge and processes needed to meet safety and efficacy standards are expensive and time-consuming but are essential investments for market approval.
• High Cost of Production: The production of high-cost adrenocortical hormone APIs often involves expensive raw materials and sophisticated technologies. Controlling production costs while ensuring product quality is crucial.
• Disruption of Supply Chains: Disruptions of supply chains may result in raw material shortages or logistical issues that affect the availability and price of hormone APIs. Therefore, it is essential to develop supply chain strategies that ensure resilience and mitigate these challenges.

The main driving factors in the adrenocortical hormone API market include technological advancement, increasing demand for targeted therapies, rising prevalence of hormonal disorders, investments in R&D, and regulatory support. Additionally, to achieve success, overcoming regulatory hurdles, managing high production costs, and addressing supply chain disruptions are critical challenges.

List of Adrenocortical Hormone API Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, adrenocortical hormone API companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the adrenocortical hormone API companies profiled in this report include-

• Pfizer CentreOne
• EuroAPI
• GlaxoSmithKline
• Teva Pharmaceutical Industries
• Hovione
• Axplora
• Steroid Spa
• Avik Pharmaceutical
• Anuh Pharma
• Symbiotec Pharmalab

Adrenocortical Hormone API by Segment

The study includes a forecast for the global adrenocortical hormone API market by type, application, and region.

Adrenocortical Hormone API Market by Type [Analysis by Value from 2019 to 2031]:

• Prednisone Series
• Dexamethasone Series
• Betamethasone Series
• Hydrocortisone Series
• Others

Adrenocortical Hormone API Market by Application [Analysis by Value from 2019 to 2031]:

• Injectable Drug
• Oral Drug
• For External Use Drug
• Inhalation Drug

Adrenocortical Hormone API Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Adrenocortical Hormone API Market

The adrenocortical hormone API market represents an evolving domain, with various key recent developments driven by advances in pharmaceutical research, regulatory changes, and further growth in demand for effective treatments. The market typically consists of hormones such as cortisol and aldosterone and is experiencing changes in different regions.

• United States: New developments involve higher investments in research and development of new formulations and delivery systems for adrenocortical hormones. This aims to enhance the efficacy and safety profiles of these APIs. Several biotech firms are advancing their clinical trials for new treatments targeting disorders of the adrenal gland.
• China: Improvements in manufacturing technologies are expanding the adrenocortical hormone API market in China. Local companies are increasing production to meet emerging demand due to rising domestic and international consumption. Additionally, the growing trend of Chinese pharmaceutical companies collaborating with global firms facilitates the development of new hormone APIs and formulations.
• Germany: The German market is experiencing changes in compliance perspectives and quality assurance processes. German pharmaceutical companies are enhancing their production cycles by introducing new technologies that improve consistency in the production of adrenocortical hormone APIs. Furthermore, the country aims to boost export volumes to meet European and global demand.
• India: The current era is witnessing growth in the adrenocortical hormone API sector. Factors contributing to this include increased investments in infrastructure and technology. Manufacturers in India seek to enhance their processes to meet international standards of product quality. They are also focusing on research and development of cost-effective hormone APIs to satisfy domestic and global market demands.
• Japan: Japan is concentrating on new formulations of adrenocortical hormone APIs and precision medicine. Japanese companies are investing in advanced research for targeted therapies and better delivery mechanisms. The country is also emphasizing partnerships with international companies to expand market exposure and develop superior products.

Features of the Global Adrenocortical Hormone API Market

Market Size Estimates: Adrenocortical hormone API market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Adrenocortical hormone API market size by type, application, and region in terms of value ($B).

Regional Analysis: Adrenocortical hormone API market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the adrenocortical hormone API market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the adrenocortical hormone API market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the adrenocortical hormone API market by type (prednisone series, dexamethasone series, betamethasone series, hydrocortisone series, and others), application (injectable drug, oral drug, for external use drug, and inhalation drug), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Adrenocortical Hormone API Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Adrenocortical Hormone API Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Adrenocortical Hormone API Market by Type
  • 3.3.1: Prednisone Series
  • 3.3.2: Dexamethasone Series
  • 3.3.3: Betamethasone Series
  • 3.3.4: Hydrocortisone Series
  • 3.3.5: Others
• 3.4: Global Adrenocortical Hormone API Market by Application
  • 3.4.1: Injectable Drug
  • 3.4.2: Oral Drug
  • 3.4.3: For External Use Drug
  • 3.4.4: Inhalation Drug

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Adrenocortical Hormone API Market by Region
• 4.2: North American Adrenocortical Hormone API Market
  • 4.2.1: North American Market by Type: Prednisone Series, Dexamethasone Series, Betamethasone Series, Hydrocortisone Series, and Others
  • 4.2.2: North American Market by Application: Injectable Drug, Oral Drug, For External Use Drug, and Inhalation Drug
• 4.3: European Adrenocortical Hormone API Market
  • 4.3.1: European Market by Type: Prednisone Series, Dexamethasone Series, Betamethasone Series, Hydrocortisone Series, and Others
  • 4.3.2: European Market by Application: Injectable Drug, Oral Drug, For External Use Drug, and Inhalation Drug
• 4.4: APAC Adrenocortical Hormone API Market
  • 4.4.1: APAC Market by Type: Prednisone Series, Dexamethasone Series, Betamethasone Series, Hydrocortisone Series, and Others
  • 4.4.2: APAC Market by Application: Injectable Drug, Oral Drug, For External Use Drug, and Inhalation Drug
• 4.5: ROW Adrenocortical Hormone API Market
  • 4.5.1: ROW Market by Type: Prednisone Series, Dexamethasone Series, Betamethasone Series, Hydrocortisone Series, and Others
  • 4.5.2: ROW Market by Application: Injectable Drug, Oral Drug, For External Use Drug, and Inhalation Drug

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Adrenocortical Hormone API Market by Type
  • 6.1.2: Growth Opportunities for the Global Adrenocortical Hormone API Market by Application
  • 6.1.3: Growth Opportunities for the Global Adrenocortical Hormone API Market by Region
• 6.2: Emerging Trends in the Global Adrenocortical Hormone API Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Adrenocortical Hormone API Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Adrenocortical Hormone API Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Pfizer CentreOne
• 7.2: EuroAPI
• 7.3: GlaxoSmithKline
• 7.4: Teva Pharmaceutical Industries
• 7.5: Hovione
• 7.6: Axplora
• 7.7: Steroid Spa
• 7.8: Avik Pharmaceutical
• 7.9: Anuh Pharma
• 7.10: Symbiotec Pharmalab